e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Exploring mechanisms in obstructive airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma
Mihaela Zidarn (Golnik, Slovenia), Mihaela Zidarn, Susan Wilson, Peter Howarth
Source:
International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Session:
Exploring mechanisms in obstructive airway diseases
Session type:
Poster Discussion
Number:
596
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mihaela Zidarn (Golnik, Slovenia), Mihaela Zidarn, Susan Wilson, Peter Howarth. Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma. Eur Respir J 2015; 46: Suppl. 59, 596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Induced sputum cytology and pulmonary function tests in ex-smoker asthmatic patients controlled with inhaled steroid and long acting beta agonist therapy
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Blockade of TSLP pathway alters asthma biomarkers
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Oxidative stress and biomarkers in patients with bronchial asthma
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept